
    
      Ketamine-induced schizophrenia-like cognitive deficits in healthy volunteers are measured by
      using touchscreen-based cognitive tests. In addition, the study aims to assess whether
      ketamine-induced cognitive deficits detected by touchscreen-based cognitive tests are
      reversed by modafinil.
    
  